One Ascent Wealth Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

One Ascent Wealth Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	BUY	$700.03 - $830.35 $11,200 - $13,285	16 Added 3.67%	452 $325,000
Q1 2023 Apr 17, 2023	BUY	$680.49 - $826.97 $63,285 - $76,908	93 Added 27.11%	436 $358,000
Q4 2022 Jan 12, 2023	SELL	$705.89 - $766.39 $9,882 - $10,729	-14 Reduced 3.92%	343 $247,000
Q3 2022 Nov 02, 2022	BUY	$573.97 - $724.32 $204,907 - $258,582	357 New	357 $246,000
Q2 2022 Aug 08, 2022	SELL	$548.35 - $738.84 $173,826 - $234,212	-317 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$595.12 - $698.43 $188,653 - $221,402	317 New	317 $221,000

1,484

83.7M

1.22M

1.5M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of One Ascent Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on One Ascent Wealth Management LLC with notifications on news.